Promisia Healthcare Limited logo

ACQUISITION OF ALDWINS HOUSE AND DIRECTOR APPOINTMENT

Director Appointment23 December 2021PHLHealthcare

Market Announcement
23 December 2021


14213097_1

ACQUISITION OF ALDWINS HOUSE AND DIRECTOR APPOINTMENT


Promisia Healthcare Limited (NZX:PHL) can advise that it has today entered a conditional agreement

to acquire Aldwins House in Christchurch. In addition, PHL has today appointed Mr Andrew Mitchell

as a director of PHL.

Aldwins Acquisition

PHL, through its wholly owned subsidiary Aldwins House Limited (AHL), currently leases Aldwins

House in Christchurch where it operates an aged care facility. Aldwins House can accommodate up

to 145 residents and the buildings have recently been refurbished and had significant earthquake

strengthening. Aldwins House has a land area of 8241m2.

AHL has entered a conditional agreement with its landlord, Teltower Limited (Vendor) to acquire

Aldwins House for $13 million. Under the agreement the Vendor has agreed to lend $4 million of the

purchase price to AHL for a four year term. The agreement is conditional on AHL securing finance of

$9 million, obtaining certain counterparty approvals and PHL obtaining shareholder approval.

Settlement is expected to occur in late March 2022 with PHL looking to call a special meeting of

shareholders in early-mid March 2022.

This acquisition is consistent with PHL’s strategy to own its aged care facilities and grow its property

portfolio. Full particulars of the acquisition will be set out in a notice of meeting next year.

Appointment of New Director

The PHL Board is pleased to advise that it has today appointed Andrew Mitchell as a director of PHL.

Andrew has worked in New Zealand, United Kingdom and Australian property markets for 20 years.

He spent 13 years at Ryman Healthcare as a Senior Executive and Chief Development Officer

overseeing the acquisition, consenting and development process throughout Australasia. During this

period, rapid acquisition and development saw the market capitalisation increase from $750m to

over $7 billion.

Andrew has expertise identifying and executing commercial strategies with a strong history of

successful outcomes. He has extensive industry contacts and experience in site identification,

negotiation, legal contracts, due diligence, site acquisition, concept design, engineering approvals,

RMA approvals and development management.

Andrew will be an executive director of PHL providing business development services to PHL.

Andrew has also today acquired a parcel of PHL shares and become a 7% shareholder of PHL. For

these reasons the Board does not consider that Andrew will be an independent director for the

purposes of the Listing Rules.


For further information please contact Mr Stephen Underwood, Chairman, on Ph 027 499 3387

ENDS

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.